This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rashidi, B. Articles by Hoffman, R. M. Search for Related Content PubMed PubMed Citation Articles by Rashidi, B. Articles by Hoffman, R. M.

An Orthotopic Mouse Model of Remetastasis of Human Colon Cancer Liver Metastasis

AntiCancer, Inc., San Diego, California 92111 [B. R., F. X. S., J. G., R. M. H.], and Department of Surgery, University of California, San Diego, California 92103-8220 [B. R., R. G., A. S., A. R. M., R. M. H.]

Whether liver metastases from colon cancer are capable of metastasizing to other sites is an important question in surgical oncology. To answer this question, we have developed a highly metastatic orthotopic transplant model of a liver metastasis from a human colon cancer patient in nude mice that targets the liver and lymph nodes. The metastatic human tumor was transplanted in athymic nude mice by surgical orthotopic implantation (SOI) of a liver metastasis from a colon cancer patient. The human colon tumor was then subsequently implanted in the colon by SOI or, in an additional series of nude mice, in the liver by surgical hepatic implantation (SHI). The mice were then explored over time for lymph node involvement beginning 10 days after implantation. After SOI, 100% of the animals had liver metastasis within 10 days, and subsequently, 19 days after SOI, all lymph nodes draining the liver were involved with metastasis without any retroperitoneal or lung tissue involvement. After SHI, all sites of lymphatic drainage of the liver, including portal, celiac, and mediastinal lymph nodes, were massively involved by metastasis in 100% of the animals as early as 10 days after tumor implantation on the liver. The results of this study demonstrate that liver metastases from colon cancer are capable of remetastasizing to other sites. This study thus suggests that in colon cancer patients with liver metastasis, mediastinal, celiac, and portal lymph node metastases originate from the liver metastasis and not, as previously thought, from primary colon cancer.

This article has been cited by other articles:

				M. V. Cespedes, C. Espina, M. A. Garcia-Cabezas, M. Trias, A. Boluda, M. T. Gomez del Pulgar, F. J. Sancho, M. Nistal, J. C. Lacal, and R. Mangues Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites Am. J. Pathol., March 1, 2007; 170(3): 1077 - 1085. [Abstract] [Full Text] [PDF]

				M. Bouvet, K. Tsuji, M. Yang, P. Jiang, A. R. Moossa, and R. M. Hoffman In vivo Color-Coded Imaging of the Interaction of Colon Cancer Cells and Splenocytes in the Formation of Liver Metastases Cancer Res., December 1, 2006; 66(23): 11293 - 11297. [Abstract] [Full Text] [PDF]

				M. Wu, R. Mazurchuk, N. D. Chaudhary, J. Spernyak, J. Veith, P. Pera, W. Greco, R. M. Hoffman, T. Kobayashi, and R. J. Bernacki High-Resolution Magnetic Resonance Imaging of the Efficacy of the Cytosine Analogue 1-[2-C-Cyano-2-deoxy-{beta}-D-arabino-pentofuranosyl]-N4-palmitoyl Cytosine (CS-682) in a Liver-Metastasis Athymic Nude Mouse Model Cancer Res., May 15, 2003; 63(10): 2477 - 2482. [Abstract] [Full Text] [PDF]

				L. FARRE, I. CASANOVA, S. GUERRERO, M. TRIAS, G. CAPELLA, and R. MANGUES Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model FASEB J, July 1, 2002; 16(9): 975 - 982. [Abstract] [Full Text] [PDF]